• The Constans score and D-dimer can rule out upper extremity deep vein thrombosis without imaging.
Introduction
Upper extremity deep vein thrombosis (UEDVT), which involves the deep veins of the arms or neck, cannot be diagnosed based on clinical features alone, because the signs and symptoms are not specific. Imaging tests, such as duplex ultrasonography, are therefore warranted to confirm or refute the diagnosis. As only 13% to 30% of patients presenting with suspected UEDVT have the disease [1] [2] [3] , duplex ultrasonography may be less desirable as a first-line test because it is time consuming and costly.
A common approach in the diagnostic management of lower extremity deep vein thrombosis and pulmonary embolism is the sequential application of a clinical decision rule and D-dimer testing, which can safely rule out these conditions and avoid imaging in 20-30% of patients. A clinical decision rule for UEDVT was proposed by Constans and colleagues in 2008, which incorporates four readily available items from medical history and physical examination: presence of an indwelling catheter, localized pain, unilateral edema or another diagnosis being at least as plausible [3] . This Constans score was derived in a retrospective single-center study (n = 140) and subsequently validated using data from a multicenter prospective study (n = 214). We have prospectively evaluated the dichotomized Constans score in combination with D-dimer testing (the Constans rule) in the diagnostic management of UEDVT, and demonstrated that this approach can safely rule out UEDVT in onefifth of patients [1] . The performance of the score itself has not been independently evaluated.
Improvements in either the Constans score or D-dimer testing could further increase the proportion of patients for whom imaging and anticoagulation can be safely withheld. The discriminatory performance of the Constans score, which now incorporates four clinical items, might be improved by extending the score with additional variables. For example, the widely used Wells scores for lower extremity deep vein thrombosis [4] and pulmonary embolism [5] consist of 10 and seven items, respectively. It has also been demonstrated that the specificity of D-dimer testing in suspected pulmonary embolism may be increased by using an age-adjusted D-dimer positivity threshold, defined as a patient's age multiplied by 10 lg L À1 in patients older than 50 years [6] . This approach has not yet been evaluated in patients with suspected UEDVT. We evaluated the performance of the Constans score, explored possible improvements in the Constans score, and compared the performance of the fixed D-dimer threshold with that of an age-adjusted D-dimer threshold.
Methods

Patients
Data collected in a prospective management study, in which a diagnostic strategy for UEDVT was evaluated, were analyzed [1] . In brief, this study enrolled 406 patients with clinically suspected UEDVT in 16 hospitals in six countries, between January 2010 and January 2012. Exclusion criteria included use of therapeutic anticoagulation for more than 24 h before inclusion, prior UEDVT in the same arm, a life expectancy of less than 3 months, hemodynamic instability, age below 18 years, or previous participation in the study. The institutional review boards of all hospitals approved the study protocol. Written informed consent was obtained from all study participants.
Diagnostic strategy
All included patients underwent a protocol-mandated sequential diagnostic strategy, which consisted of the Constans score, quantitative D-dimer testing and ultrasonography. The Constans score estimates the clinical probability of UEDVT from the following clinical items: presence of a central venous catheter or pacemaker (+1 point), localized pain (+1 point), unilateral edema (+1 point), and another diagnosis being at least as plausible as UEDVT (À1 point) [3] . With a Constans sum score of 1 point or less a patient is classified as 'UEDVT unlikely'; a score of 2 points or more classifies a patient as 'UEDVT likely'. In patients with a 'UEDVT unlikely' Constans score, D-dimer testing was performed using the locally available method, which was either a quantitative latex-based assay or an enzyme-linked immunosorbent assay. UEDVT was considered ruled out in patients who were classified as 'UEDVT unlikely' and had a D-dimer below the local, fixed threshold, which usually was 500 lg L
À1
. In these patients, imaging was withheld and no anticoagulant therapy was initiated. Patients with a 'UEDVT likely' Constans score and those with a 'UEDVT unlikely' Constans score but positive D-dimer testing, underwent ultrasonography and, in selected cases, repeat ultrasonography after 3-5 days.
All patients in whom the initial diagnostic work-up had excluded thrombosis were followed for 3 months for the occurrence of symptomatic UEDVT or pulmonary embolism. All suspected outcomes were adjudicated by an independent committee whose members were unaware of the patients' diagnostic management.
Performance of the Constans score
In the present study, we evaluated the performance of the Constans score and age-adjusted D-dimer testing. The discriminative performance of the Constans score was assessed by calculating the area under the receiver operating characteristics (ROC) curve, with 95% confidence intervals (CIs) obtained by DeLong's method. A calibration curve was plotted to visualize the agreement between the calculated probabilities and observed proportions of UEDVT for each possible Constans score. In the absence of a reported intercept for the Constans score model, an intercept for the calibration plot was estimated using a multivariate logistic regression model, with the Constans score items as offset. We did not use the Hosmer-Lemeshow test to formally evaluate the goodness of fit of the Constans score because this test has poor power in the case of a limited number of groups.
We calculated estimates of the sensitivity, specificity, positive predictive value and false-negative rate of the dichotomized Constans score in detecting UEDVT. The positive predictive value was estimated as the number of patients with a diagnosis of UEDVT and a Constans score of two or higher relative to all patients with a Constans score of two or higher. The false-negative rate was estimated as one minus the negative predictive value: the number of patients with a diagnosis of UEDVT and a Constans score below two relative to all patients with a Constans score below two. These estimates were compared with the ones reported in the derivation, internal validation and external validation cohorts by Constans and colleagues [3] .
A multivariable logistic regression model was built with the original Constans items as predictors and a final diagnosis of UEDVT as the dependent variable. The adjusted odds ratios derived from this model were compared with those originally reported by Constans and colleagues.
Because it is well known that clinical prediction scores for venous thromboembolism may perform poorer in hospitalized patients [7, 8] , all analyses were repeated in a sensitivity analysis restricted to outpatients.
Exploring improvements of the Constans score
We evaluated whether the following a priori defined variables were able to improve the discriminatory performance of the Constans score: age (continuous), male sex, immobilization for more than 3 days, arm swelling with a diameter of more than 1.5 cm compared with the other arm, paralysis or plaster cast immobilization, major surgery within the past 4 weeks, temperature above 38.5°C, inpatient status, trauma to the shoulder or arm within the past 6 weeks, an intravenous injection or a peripheral catheter within the last 5 days, estrogen use, previous venous thromboembolism (VTE), known thrombophilia, active cancer, skin color difference, a palpable cord, frequent repetitive movements of the arm, superficial vein dilatation, a dysfunctional arm, and dyspnea or thoracic pain. These variables were selected because they are wellknown risk factors for venous thrombosis or signs and symptoms known to be indicative of UEDVT.
The association of each of these variables with UEDVT was first evaluated by univariate logistic regression modelling. Variables that were associated with UEDVT at a significance level < 0.20 were entered into a multivariable model, together with the original Constans score items. We did not include all candidate variables in the multivariate model because this would have resulted in approximately four outcome events per variable, thereby potentially increasing the risk of selecting irrelevant variables. To arrive at a parsimonious model, we then eliminated all items not significantly associated with UEDVT at a significance level of 0.05, using stepwise backward elimination, while forcing the original Constans score items to remain in the model. This way, only variables that had significant incremental value conditional on the original Constans items were selected for the final model.
Based on the final model, an extended Constans score was calculated by assigning 1 extra point to each variable with a positive association and À1 point to each variable with a negative association with UEDVT, similar to the derivation procedure of the original Constans score. The performance of this extended score was evaluated by calculating the area under the ROC curve and drawing a calibration plot. The area under the ROC curve of the extended Constans score was compared with that of the original Constans score using DeLong's test [9] . The extended Constans score was dichotomized by selecting the cut-off with optimal sensitivity.
Clinical performance of the original Constans score combined with D-dimer testing
Because the Constans score cannot safely exclude the diagnosis of UEDVT alone, it has to be used in conjunction with D-dimer testing. We evaluated the efficiency and failure rate of this combination. Efficiency was defined as the proportion of patients for whom imaging and anticoagulation could be withheld based on a Constans score of 1 point or less ('UEDVT unlikely') and a negative D-dimer. The failure rate was defined as the proportion of patients with symptomatic UEDVT or pulmonary embolism during 3-month follow-up among those in whom UEDVT was considered ruled out based on a Constans score of 1 point or less and a negative D-dimer. The strategy was considered safe if the upper limit of the 95% confidence interval of the failure rate was below 3%, which is a common safety margin in diagnostic VTE studies. Two different D-dimer positivity thresholds were evaluated: the conventional, fixed threshold and an ageadjusted threshold, defined as a patient's age multiplied by 10 lg L À1 in patients aged 51 years or older. For example, age-adjusted D-dimer testing in a 70-year-old patient would lead to a D-dimer positivity threshold of 700 lg L À1 .
Data analysis
After careful review of all records, 16 patients (4%) appeared to have been erroneously classified by the study physician as having a central venous catheter, when in fact they had a peripheral catheter inserted. For these patients, a recalculated Constans score based on the absence of a central venous catheter was used in the analysis of the performance of the Constans score. Differences between categorical variables were assessed with the chisquared test. Binomial proportion 95% confidence intervals were based on the Wilson score interval. A significance level of 0.05 was used in statistical testing. Statistical analyses were performed in R, version 3.2.3 (R Foundation for Statistical Computing, Vienna, Austria, www.R-project.org).
Results
Baseline characteristics of the study group of 406 patients with suspected UEDVT are summarized in Table 1 . The mean age was 57 years and 45% were male. Overall, UEDVT was diagnosed in 103 patients at baseline and in one patient during follow-up (26%; 95% CI, 22-30%).
Performance of the Constans score
The median Constans sum score was 1 (interquartile range, 1-2); 211 patients (52%) had a Constans score of 1 point or less (Table 1) . Of the items in the Constans rule, the one most frequently observed was localized pain (n = 325, 80%), whereas the item 'presence of CVC or pacemaker' had the lowest frequency (n = 92, 23%).
The area under the ROC curve for the Constans score, which reflects its discriminatory performance in detecting UEDVT, was 0.81 (95% CI, 0.76-0.85; Fig. 1, solid line) . This AUC is higher than the area under the ROC curve reported in the derivation study by Constans and colleagues (Table 2 ) [3] .
Visual inspection of the calibration plot, which illustrates the agreement between calculated probabilities and observed proportions, demonstrated that the Constans score tended to underestimate the probability of UEDVT at lower scores and to overestimate it at higher scores ( Fig. 2; solid line) . The sensitivity of the dichotomized Constans score (≥ 2 points) in detecting UEDVT was 0.86 (95% CI, 0.78-0.91) at a specificity of 0.65 (95% CI, 0.59-0.70). This sensitivity is higher than in the derivation study by Constans and colleagues, whereas the specificity is lower (Table 2) . Fifteen (7.1%) of the 211 patients classified as 'UEDVT unlikely' had a final diagnosis of UEDVT versus 89 (46%) of the 195 patients classified as 'UEDVT likely' (relative risk, 6.4; 95% CI, 3.9-11; Table 2 ).
In the multivariable analysis, the odds ratios of the Constans score items 'localized pain' and 'unilateral edema' were lower in the current analysis than in the study by Constans and colleagues, whereas 'presence of a central venous catheter or pacemaker' and 'other diagnosis at least as plausible' were stronger predictors of UEDVT (Table 3 ). The results of the sensitivity analysis, restricted to outpatients, were comparable to the results of the overall analysis (data not shown).
Exploring improvements of the Constans score
The associations of the 20 candidate predictors with UEDVT are summarized in Table S1 . Eight predictors were associated with UEDVT at a significance level of < 0.20 in the univariate analysis and were included in a multivariable logistic regression model together with the four Constans score items. After backward stepwise elimination, the following five variables were retained in the final, extended model with the Constans score items: superficial vein dilatation (odds ratio, 5.3), arm swelling > 1.5 cm compared with the other arm (odds ratio, 3.8), estrogen use (odds ratio, 2.9), skin color change (odds ratio, 1.9), and intravenous injection or presence of peripheral venous catheter < 5 days (odds ratio, 0.28) ( Table 3) .
Based on the items in this model, an extended Constans score was calculated in which 1 extra point was assigned based on the presence of superficial vein dilatation, arm swelling > 1.5 cm compared with the other arm, estrogen use or skin color difference, and À1 point in the case of an intravenous injection or peripheral venous catheter in the past 5 days. The area under the ROC curve of this extended score was 0.85 (95% CI, 0.81-0.89), compared with 0.81 (95% CI, 0.76-0.85) of the original Constans score (P = 0.02; Fig. 1, dashed line) . The extended score was well calibrated ( Fig. 2; dotted line) .
The extended Constans score was dichotomized by classifying patients with a score of 2 points or less as 'UEDVT unlikely' and those with 3 points or more as 'UEDVT likely'. This extended Constans rule had a sensitivity and specificity for the diagnosis of UEDVT of 0.90 (95% CI, 0.83-0.95) and 0.64 (95% CI, 0.59-0.69), respectively ( Table 2 ). The incidence of UEDVT in the 249 patients with a 'UEDVT unlikely' result on the extended rule was 4.9% (95% CI, 2.7-8.8%) compared with 47% (95% CI, 40-53%) in those classified as 'UEDVT likely' (relative risk, 9.5; 95% CI, 5.1-18; Table 2 ). The proportion of patients for whom imaging and anticoagulation could have been withheld based on the extended Constans score of 2 points or less and a negative, fixed D-dimer was 21% (95% CI, 17-25%), which is similar to the efficiency of the original Constans score and a negative fixed D-dimer (21%; 95% CI, 18-26%).
Constans score combined with age-adjusted D-dimer testing
Among the 203 patients classified as 'UEDVT unlikely' by the study physicians, 87 patients (43%) had a D-dimer below the fixed threshold, 15 (7.4%) had a D-dimer between the fixed and age-adjusted thresholds, and 98 (48%) had a D-dimer above the age-adjusted threshold. D-dimer testing was not performed in three patients (1.5%). As a consequence, by applying the age-adjusted D-dimer threshold, the efficiency of the algorithm increased from 21% (95% CI, 18-26%) to 25% (95% CI, 21-30%), corresponding to a gain in efficiency of 3.7% (95% CI, 2.3-6.0%). Among outpatients, age-adjusted Ddimer testing increased the efficiency from 26% (95% CI, 21-31%) to 30% (95% CI, 26-36%).
No patients in whom UEDVT was considered ruled out based on a 'UEDVT unlikely' Constans score and a D-dimer below the fixed threshold developed symptomatic VTE during 3-month follow-up (failure rate, 0%; 95% CI, 0-4.2%). No patients with a D-dimer between the fixed and age-adjusted thresholds had UEDVT at baseline or developed VTE during follow-up (failure rate age-adjusted D-dimer testing, 0%; 95% CI, 0-3.6%). Among the 64 patients (16%) who were 75 years or older, age-adjusted D-dimer testing increased the efficiency from 13% to 19% (gain, 6.3%; 95% CI, 2.5-15.0%), whereas efficiency increased from 18% to 24% (gain, 5.8%; 95% CI, 3.3-10%) among the 190 patients aged 51-75 years (Fig. 3) .
Discussion
We were able to confirm the good discriminatory performance of the Constans score in the diagnosis of UEDVT. Although an extended Constans score with five additional clinical items improved the discriminatory performance, it did not result in greater efficiency when applied dichotomously. The results also suggest that ageadjusted D-dimer testing can safely increase the proportion of patients for whom imaging can be withheld, by approximately 4%.
The diagnostic algorithm for UEDVT evaluated in this study is very similar to the widely used algorithms in patients with suspected pulmonary embolism and lower extremity deep vein thrombosis. The sequential application of a clinical score and D-dimer testing proved to be safe in a previous management study [1] . The present results indicate that the original Constans score is able to discriminate between patients at low and high risk of UEDVT effectively, as reflected by an area under the ROC curve of 0.81. In comparison, the area under the ROC curves for the Wells and revised Geneva scores, two widely used clinical probability scores for pulmonary embolism, are 0.79 and 0.73, respectively [10] . When the Constans score was used dichotomously, it could better discriminate between the 'likely' and 'unlikely' categories than the Wells rule (relative risk, 6 vs. 3) [11] .
It is well known that odds ratios may show an upward bias in derivation studies, as a result of over-fitting, and that validation studies often report lower values. In the present analysis, however, we did not observe such an effect. In fact, the association of two of four items in the Constans score with UEDVT was even stronger than in the original study, which reinforces the predictive value of these items. Moreover, the discriminatory performance of the Constans score, as reflected by the area under the ROC curve, was higher in the present analysis than in the previous report by Constans and colleagues, which reinforces their findings.
To explore whether the performance of the Constans score could be further improved, we evaluated the incremental value of five clinical variables, each associated with UEDVT conditional on the original Constans score items. The extended Constans score, which Efficiency is defined as the proportion of patients for whom imaging could be withheld based on a 'UEDVT unlikely' Constans score and a negative D-dimer comprised nine items, showed significantly better discriminatory performance and calibration than the original score. In other words, the extended score better distinguished between patients at low and high risk of UEDVT and more adequately predicted the actual risk of UEDVT, with higher scores indicating greater risk. Although such a score could be helpful in the clinical assessment to predict the absolute risk of UEDVT, the extended Constans rule in combination with D-dimer testing did not result in an increased efficiency and its use can therefore not be recommended. Moreover, the extended Constans score is harder to memorize (nine vs. four items), which hampers its clinical applicability. Hence, we propose to leave the Constans score unchanged in clinical practice.
The use of an age-adjusted D-dimer threshold has now become the standard in the diagnostic management of pulmonary embolism because it increases the proportion of patients for whom diagnostic imaging can be withheld without jeopardizing safety [6, 7] . Our results indicate that such an approach could also be feasible in patients with suspected UEDVT. Using an age-adjusted D-dimer threshold instead of a fixed threshold, the efficiency increased from 22% to 26% in the present analysis, which is in line with the efficiency gains seen in the diagnostic management of pulmonary embolism [7] . As expected, the relative and absolute gain of age-adjusted D-dimer testing was most pronounced in elderly patients. Although no patients with a 'UEDVT unlikely' Constans score and negative age-adjusted D-dimer had symptomatic VTE during 3-month follow-up, the upper limit of the 95% confidence interval of the failure rate exceeded the a priori defined safety margin of 3%. A larger prospective study would therefore be needed to estimate the failure rate of age-adjusted D-dimer testing with more precision.
Several aspects of the present study require comment. The analyses were based on data collected in a prospective cohort study in which a broad spectrum of consecutive patients from six different countries was included. We feel that this contemporary study group is representative of the population with suspected UEDVT encountered by physicians today. The safety of the diagnostic algorithm was evaluated by the 3-month incidence of symptomatic UEDVT or pulmonary embolism in those patients in whom the disease was considered ruled out by an 'UEDVT unlikely' Constans score and negative Ddimer. Although this clinical outcome is not a perfect reference standard for diagnostic research, it is widely accepted in diagnostic management studies for suspected venous thromboembolism [6, 12, 13] .
The extended Constans score was calculated by assigning one point to each item significantly associated with UEDVT conditional on the original Constans score items. Alternatively, we could have assigned points based on the regression coefficients obtained in the multivariable analysis, which is common practice in the development of clinical prediction rules. However, when the possibility of over-fitting is not taken into account, as in the derivation study by Constans and colleagues, this could result in upwardly biased coefficients and an overestimation of the predictive value of items [14] . To avoid this bias and to keep the score as simple and clinically applicable as possible, we evaluated the score by assigning one point to each item.
D-dimer levels were measured using the locally available D-dimer testing method, which could be a quantitative latex-based assay or an enzyme-linked immunosorbent assay. These modern assays have a high sensitivity in the diagnosis of UEDVT, but their specificity varies [15] . We were unable to evaluate the performance of each D-dimer assay separately given the limited number of patients and our results on the efficiency of age-adjusted D-dimer testing may therefore not be generalizable to all D-dimer assays. Although it is reassuring that the efficiency and safety of age-adjusted D-dimer testing in the diagnosis of pulmonary embolism appeared to be homogeneous across six different D-dimer assays [6] , it is unknown whether this holds true for UEDVT as well.
The Constans rule for the diagnostic management of UEDVT has good discriminatory performance and is simple to use in clinical practice. Extending the score with additional items did not result in an increase in efficiency. If the Constans score is used in conjunction with age-adjusted D-dimer testing, imaging tests may be avoided in a quarter of patients with suspected UEDVT, with greatest efficiency among the elderly. As this approach provides a simple way to improve the diagnostic management of UEDVT, we feel it deserves further study.
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